From Yahoo Finance: 2025-06-04 23:50:00

Recursion Pharmaceuticals, Inc. (RXRX) saw a significant 11.85% increase in share price on Wednesday, closing at $4.91 per share. This surge came after positive comments from an analyst and a “buy” recommendation from Jim Cramer on Mad Money. The company is backed by Nvidia and is poised to benefit from the FDA’s move towards AI in drug approval processes.



Read more at Yahoo Finance: Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today